IQVIA Pharma Deals Half-Year Review of 2022
By Heather Cartwright, Taskin Ahmed & Lucy Haggerty
Pharma Deals Review: Vol 2022 Issue 10 (Table of Contents)
Published: 14 Oct-2022
DOI: 10.3833/pdr.v2022.i10.2733 ISSN: 1756-7874
Section: Opinion & Analysis
Fulltext:
Abstract
Deal activity in the life sciences sector in H1 2022 was unable to match the pandemic-boosted level seen in H1 2021 as challenging market and economic conditions deterred companies from pursuing certain types of transactions...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS